SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-21-000427
Filing Date
2021-04-15
Accepted
2021-04-14 19:31:52
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLCORBIMED CAPITAL LLCORBIMED GENESIS GP LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss227171_sc13d.htm SC 13D 137613
2 JOINT FILING AGREEMENT ss227171_ex9901.htm EX-99.1 7928
  Complete submission text file 0000947871-21-000427.txt   147107
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Subject) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92449 | Film No.: 21826960
SIC: 2836 Biological Products, (No Diagnostic Substances)